ArticleNeurotoxicity research2025
Novel in silico Evidence of Bisphenol A as a Neuroinflammatory Modulator through the cGAS-STING-NLRP3 Pathway.
Article in Neurotoxicity research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bisphenol A (BPA), a widely prevalent environmental contaminant, has been linked to neuroinflammation; however, the molecular mechanisms underlying this effect remain unclear. In this study, we used molecular docking and molecular dynamics simulations to predict the interactions of BPA with key proteins in the cGAS-STING-NLRP3 signaling pathway, an innate immune axis implicated in neuroinflammatory diseases. BPA demonstrated higher predicted binding affinity to these proteins than the reference neurotoxicant rotenone, suggesting a potential to interact with and modulate this pathway. Molecular dynamics simulations indicated stable binding of BPA, with possible structural adaptations observed in cGAS and NLRP3 proteins, which may influence downstream inflammatory signaling. Since this pathway plays a role in neurodegeneration by sensing cytosolic DNA and activating the NLRP3 inflammasome and type I interferon responses, our computational findings raise the possibility of a previously unrecognized route for BPA-mediated neuroimmune modulation, distinct from oxidative stress or NF-κB activation. These predictions underscore the need for further experimental validation and provide a basis for future research into the mechanistic underpinnings and therapeutic targeting of BPA-induced neurotoxicity.
Indexed as
Identifiers
41212314What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.